Andexanet to reverse apixaban or rivaroxaban anticoagulation.
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 41, doi. 10.1002/psb.1791
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2019 AND VI 30 AND IP 9
Results: 7
1
2
Monoclonal antibodies for the treatment of plaque psoriasis.
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 35, doi. 10.1002/psb.1790
- By:
- Publication type:
- Article
3
Monitoring drug safety: is the Yellow Card Scheme struggling?
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 32, doi. 10.1002/psb.1789
- By:
- Publication type:
- Article
4
Impact of the Avastin case on prescribing medicines off‐label.
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 28, doi. 10.1002/psb.1788
- By:
- Publication type:
- Article
5
A comprehensive guide to the management of anaemia.
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 19, doi. 10.1002/psb.1787
- By:
- Publication type:
- Article
6
Dealing with the pressure of glaucoma management.
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 11, doi. 10.1002/psb.1786
- By:
- Publication type:
- Article
7
No 'getting away from it all' on a US holiday.
- Published in:
- Prescriber, 2019, v. 30, n. 9, p. 4, doi. 10.1002/psb.1785
- By:
- Publication type:
- Article